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ABSTRACT 
Micronutrients are class of dietary components which are highly essential for the optimal health, 
growth, and development. These nutrients can overcome birth defects, maternal impairment, and 
increased risk of death. According to 2017 statistics, around 2 billion people in the developing 
countries are affected by micronutrient deficiency. There are around 13 essential vitamins which 
are found in nature. Vitamin B is more important as it plays a vital role in maintaining good health 
and well-being. Among several existing forms, the native and active form of vitamin B6 is PLP 
(pyridoxal 5- phosphate). PLP is a co-factor for several biochemical reactions and plays an 
imperative role in synthesis of amino acids, carbohydrates and fatty acids. Vitamin B6 
supplementation in RDA showed to be highly health promising in controlling several clinical 
alignments such as cardiovascular disease, diabetes, neurological disease, premenstrual syndrome, 
stroke, peripheral vascular disease, coronary artery disease, pellagra skin disease, ataxia, 
hyperacuosis, suppression of colon tumor genesis and hyper irritability. Recently, it has been 
reported that 43.8% people are suffering from cardiovascular disease followed by stroke (16.8%) 
and is also expected to reach up to1.1 trillion by the end of 2035. It has been found that vitamin 
B6 lowers Homocystein in blood, which damages the inner linings of arteries causing blood clots 
and thereby reducing the symptoms of cardiovascular diseases. In addition to it humans have to 
depend on dietary sources of vitamin B6 which are produced by plants, fungi and bacteria. The 
present review currently focuses on the action of Vitamin B6 in the management of cardiovascular 
diseases.  
Keywords: Vitamin B6, Homocystein, cardiovascular diseases. 
 
1. INTRODUCTION  
 Vitamins are naturally occurring organic compounds that were highly essential for an 
organism for its vital growth and are available in little amount in selected sources. Pyridoxine 
(vitamin B6) is a class of water soluble vitamins which is highly vital for the conversion of 
nutrients into energy form and also responsible for cellular metabolism. In addition to that vitamin 
B6 molecule posse high Ross avenging and ROSquenching activity. They are also involved in 
human catabolism and anabolism processes [1, 26]. However, vitamin B6 deficiency in humans 
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leads to cardiovascular disease, hypertension, epilepsy, diabetes, kidney disease, neurological 
disorders, and pellagra [12]. 
 Vitamin B6 is a metabolic enhancer and is also a versatile co-factor for around 200 
biochemical reactions. Several form of vitamin B6 exist naturally which includes pyridoxine(PN), 
pyridoxal(PL),pyridoxine(PM), and pyridoxal derivatives pyridoxal 5’-phosphate (PLP), 
pyridoxine 5’-phosphate (PNP), and pyridoxine 5’-phosphate (PMP)[7].Out of these forms, PLP 
is the most active form because of its ability to synthesis amino acids, fatty acids and 
carbohydrates by transaminations, decarboxylations and racemisations.[23,26].According to the 
recommended dietary allowances (RDA) for vitB6, United States Food and Nutrition Board of the 
Institute of Medicine reported adults to consume about 1.3 mg, 1.7 mg (adult males) and 2 mg for 
lactating women. Vitamin B6 could play a vital role in protecting cells from oxidative stress 
because it exhibits antioxidant activity that is more powerful than vitamins C or E.It plays a 
crucial role in the biosynthesis of neurotransmitters, gluconeogenesis and glycogenolysis, 
improves immune function, aids in haemoglobin formation, and involves in development of brain. 
They are helpful in maintaining the levels of Homocystein in the blood [3,5,25]. Jejunum is the 
only region which absorbs vitamin B6 in our body. In adults it is proved that 30 nmol/L of active 
PLP is Phosphorylated and dephosphorylated to obtain an adequate pool of vitamins B6 in the 
human body [(3]. The Food and Nutrition Board (FNB) at the Institute of Medicine of the 
National Academies (formerly National Academy of Sciences) uses plasma PLP level of 20 
nmol/L to calculate the Recommended Dietary Allowances (RDAs) of vitamin B6 in adults [23]. 
Fitzpatrick et al.,8 reported that plants, bacteria, fungi are the major sources which are able to 
biosynthesis vitamin B 6 so subsequently animals and humans have to depend on it. Cheng et .al 
[6] reported that the vitamin B6 is commonly available in the form of pyridoxine hydrochloride 
(HCl) and PLP. Generally this Vitamin B6 is available in the form of multivitamins because this is 
very easy way for a common human being to intake. But due to the lack of such vitamins people 
are substantially depending on vitamins from other sources. As report says that multivitamins 
have got several advantages and disadvantages when they are taken in diet because usually body 
absorbs large pharmacological doses of vitamin B6, but it also quickly eliminates large amount of 
vitamins out. 
 In plants, vitamin B6 protects photosynthesis process thereby helps to alleviate both a 
biotic and biotic stress [11]. 
 
HOMOCYSTEIN 
 Homocystein is a dietary form of amino acid which is produced due to low intake of B12, 
B6 and B9. Other factors responsible for increase in levels of homocystein could be due to genetic 
level changes and environmental conditions. It has been found that high level of homocystein 
blood damages the inner linings of arteries causing blood clots leading to clinical conditions 
(https://www. webmd.com/heart-disease/guide/homocystein risk). This problem can be controlled 
by administering vitamin B6 and intake B6 rich food crops as they reduce the symptoms of 
cardiovascular diseases (fig. 1) such as heart disease and rare inherited disorders[1,10]. 
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Figure 1: Homocystein and their fundamental roles in causing diseases(source: Caterina Tinelli et al., 2019) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.2: Vitamins and their forms 
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VITAMIN B6 RICH FOOD CROPS 
 In United States, mostly adults obtain vitamin B6 from various dietary sources such as 
fortified cereals, beef, poultry, starchy vegetables, and some non-citrus fruits because these are the 
richest source of vitamin B6. The bioavailability of vitamin B6 is around 75% [27]. 
Table.1 Vitamin B6 rich food sources and their daily value in (mg) [2,17]. 
Food 
Milligrams (mg) per 
serving 
Percent 
DV* 
Chickpeas, canned, 1 cup 1.1 55 
Beef liver, pan fried, 3 ounces 0.9 45 
Tuna, yellowfin, fresh, cooked, 3 ounces 0.9 45 
Salmon, sockeye, cooked, 3 ounces 0.6 30 
Chicken breast, roasted, 3 ounces 0.5 25 
Breakfast cereals, fortified with 25% of the DV for 
vitamin B6 
0.5 25 
Potatoes, boiled, 1 cup 0.4 20 
Turkey, meat only, roasted, 3 ounces 0.4 20 
Banana, 1 medium 0.4 20 
Marinara (spaghetti) sauce, ready to serve, 1 cup 0.4 20 
Ground beef, patty, 85% lean, broiled, 3 ounces 0.3 15 
Waffles, plain, ready to heat, toasted, 1 waffle 0.3 15 
Bulgur, cooked, 1 cup 0.2 10 
Cottage cheese, 1% low-fat, 1 cup 0.2 10 
Squash, winter, baked, ½ cup 0.2 10 
Rice, white, long-grain, enriched, cooked, 1 cup 0.1 5 
Nuts, mixed, dry-roasted, 1 ounce 0.1 5 
Raisins, seedless, ½ cup 0.1 5 
Onions, chopped, ½ cup 0.1 5 
Spinach, frozen, chopped, boiled, ½ cup 0.1 5 
Tofu, raw, firm, prepared with calcium sulfate, ½ cup 0.1 5 
Watermelon, raw, 1 cup 0.1 5 
*DV = Daily Value. 
(Source:https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/) 
 
EPIDEMIOLOGIC EVIDENCE  
Vitamin B6 as a Risk Factor for Cardiovascular Disease 
 Many scientists have reported that vitamin B6 is one of the most important co factors 
which are a regulator in the Homocystein metabolism. When intake of this nutrient is very low 
that simultaneously causes higher accumulation of Homocystein in the blood plasma(13,14).More 
over for past 20 years, it is described  that  Homocystein amino acid and  its elevated plasma 
concentration has got high position as it is a risk factor for causing various vascular diseases 
(fig.3,6) such as coronary heart diseases(15), stroke, and thrombosis (9,27). Cui Ret al [7] 
reported that Homocystein associated diseases could be controlled by administering vitamin B6 as 
a dietary intake. The authors report revealed that administration of with vitamin B6 (50mg/l) 
reduced Homocystein levels and 25% of stroke and cardiovascular disease was decreased [29].In 
another study, SaposnikG, [25]observed that supplementation of dietary vitamin B6 reduced the 
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levels of   Homocystein for about 3µmol/l. Cui Ret al [7]claimed that vitamin B6 intake reduced 
Homocystein level and prevented from cardiovascular disease (11%), stroke risk (19 %), and heart 
failure among Japanese population with a follow up for 14 years. Hyperhomocysteinemia is 
another condition where elevated levels of Homocystein get accumulated in the human body 
which results in premature atherosclerosis that leads to an increased risk of cardiovascular events 
[5] 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.3 Homocystein molecule injuring arterial walls 
(Source:https://drjockers.com/cardiopower-testing) 
 On the other hand, Huang YCet al [17] reported that there was no effect of vitamin B6 
supplementation (50 mg/day) in combination with 2.5 mg folic acid and 1 mg vitamin B12 on 
decreasing cardiovascular disease risk.  
 In another clinical trial study, vitamin B6 (40mg/day) supplementation showed no benefit 
with or without folic acid (0.8 mg/day) plus vitamin B12 (0.4 mg/day) on major cardiovascular 
events in patients with ischemic heart disease [15]. 
 
HOMOCYSTEIN METABOLISM  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.4: Homocysteinmetabolismpathway 
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(Source:https://www.intechopen.com/books/the-mystery-of-glaucoma/homocysteine-in-the-
pathogenesis-of-chronic-glaucoma) 
 
Vitamin B6 andStroke 
 Saposnik G,[25] proved that vitamin B6 is helpful in solving stroke which is a big problem 
currently the world is facing. Recently, it has been reported that 43.8% people are suffering from 
cardiovascular disease followed by stroke (16.8%) and is also expected to reach up to1.1 trillion 
by the end of 2035.WhenHomocystein-lowering therapy (HLT) was carried out with appropriate 
dose of vitamin B6 reduced the incident risk of stroke.BDNF are a class of proteins found in brain 
which is helpful in controllingdrinking, consumption, and body encumbrance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.5: Role of vitamin b6 in alleviating stroke Vitamin B6 and Coronary Artery Disease (Frizo et al., [26]). 
  
 
 
 
 
 
 
 
 
 
 
 
Figure.6 Mechanism for low vitamin B6 Atherogenesis( Frizo et al., [26]) 
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 On the other hand NAMPT (nicotinamidephosphoribosyltransferase) is a multifunctional 
protein which helps to improve post-stroke recovery, enhancing the proliferation of endothelial 
cells, inhibiting apoptosis, regulating vascular tone, and stimulating autophagy in disease 
conditions such as stroke. When vitamin B6 was administered this act as anti-stroke agent and 
helpsin up regulating the two major genes BDNF (Brain-derived growth factor) and NAMPT( 28, 
fig.5) Studies reported that there is an association between low plasma vitamin B6 (Fig.6) and 
higher risk of coronary artery disease which can leads to major thrombotic complication and 
myocardial infarction. Zhao et al[31]explained thathomocystein-relatedfactors including B6 
vitamin are associated with the incidence of coronary artery disease.  
Table.2 Mechanisms for vitamin B6 related Atherogenesis 
Mechanism Description References 
 
Homocysteine 
metabolism 
 
Vitamin B6 deficiency induces 
Hyperhomocys-teinemia 
through inhibition of 
cystathionine-β-synthase 
 
 
Clarke and Lewington (2002), D’Angelo 
and Selhub (1997), Eikelboom et al. 
(1999), Finkelstein (1998), McCully 
(1970), McCully and Ragsdale (1970) 
 
Coagulation 
pathway 
 
 
Vitamin B6 affects platelet 
aggregation by inhibiting 
ADP receptors and prolong 
bleeding time, Occupancy of 
glycoprotein IIb/IIIa receptor 
or down-regulation of 
glycoprotein IIb gene 
Brattstrom et al. (1990), Brownlee et al. 
(1984), Cattaneo et al. (2001), Chang 
et al. (1999, 2002), Packham et al. 
(1981) 
 
Arterial wall 
degeneration 
 
Impairment of lysyl oxidase 
activity by vitamin B6 
deficiency induces arterial 
wall degeneration. Vitamin 
B6 also inhibits endothelial 
cell proliferation and induce 
endothelial dysfunction 
 
Bruel et al. (1998), Ji et al. (2003), Levene 
and Murray (1977), Matsubara et al. 
(2003, 2004), Murray and Levene 
(1977), Rodriguez et al. (2002), 
Woessner (1991) 
Cholesterol 
metabolism 
 
Inhibition of advanced glycation 
and lipoxidation end-products 
by Vitamin B6 deficiency 
induces hypercholesterolemia 
 
Brattstrom et al. (1990), de Gomez Dumm 
et al. (2003), Degenhardt et al. (2002), 
Kirsten et al. (1988), Knipscheer et al. 
(1997), Metz et al. (2003) 
Fatty acids 
composition 
 
Vitamin B6 deficiency impairs 
conversion of linoleic acid to 
arachidonic acid and the 
metabolism of n-3 PUFA 
from alpha-linoleic acid to 
eicosapentaenoic and 
docosahexaenoic acid 
 
Bordoni et al. (1998), Cabrini et al. 
(2001), Cunnane et al. (1984), Harris 
et al. (2006), Kirschman and Coniglio 
(1961), Tsuge et al. (2000) 
Immunological 
function 
 
Vitamin B6 deficiency impairs 
T lymphocyte and 
macrophage differentiation 
and interleukins production 
 
Meydani et al. (1992), Rall and Meydani 
(1993), Roubenoff et al. (1995) 
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Later it was concluded that supplementation of B6 vitamins successively reduced Coronary Artery 
Disease for about 50%. 
 
CONCLUSION 
 The beneficial supplementation of vitamin B6 helps in solving many epidemiological 
actions which include Coronary Arterary Diseases, stroke and atherosclerosis which is 
consequentially called as cardiovascular diseases. 
 Owing to the progressive malnutrition, alcoholism, or pharmacological therapy, people are 
suffering from vitamin B6 deficiency. Due to the Vitamin B6 deficiency, levels of homocystein 
consequently gets boosted up and they function irregularly. Considering that pyridoxine (Vitamin 
B6) plays a crucial role in the development and functioning of brain, this supplementation of 
vitamin helps in solving the problems related to cardiovascular diseases. Thus, vitamin B6 is one 
of the strong candidates that can be helpful in alleviating cardiovascular diseases. 
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